Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • weitere Studien Pharmaindustrie / Gesundheit
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bulgarien
  • Dänemark
  • Deutschland
  • Estland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Island
  • Italien
  • Kroatien
  • Lettland
  • Litauen
  • Luxemburg
  • Malta
  • Mazedonien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vereinigtes Königreich
  • Weißrussland
  • Weißrussland
  • Zypern
  • Asien / Pazifik
  • Bangladesch
  • China
  • Fiji
  • Hong Kong
  • Indien
  • Indonesien
  • Japan
  • Kasachstan
  • Malaysia
  • Neuseeland
  • North Korea
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Turkmenistan
  • Usbekistan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Algerien
  • Ghana
  • Guinea
  • Irak
  • Iran
  • Israel
  • Katar
  • Kenia
  • Kuwait
  • Libyen
  • Marokko
  • Nigeria
  • Saudi Arabien
  • Simbabwe
  • South Africa
  • Tunesien
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Brasilien
  • Chile
  • Costa Rica
  • Kolumbien
  • Mexiko
  • Nicaragua
  • Paraguay
  • Peru
  • Trinidad und Tobago
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • BBE RETAIL EXPERTS
  • Business Insights
  • Canadean
  • cbc market intelligence
  • Datamonitor
  • Euromonitor
  • Experton Group AG
  • GBI Research
  • Global Markets Direct
  • Global Research & Data Services
  • GlobalData
  • ICD Research
  • IFH RETAIL CONSULTANTS GmbH
  • Koncept Analytics
  • Life Science Analytics
  • MarketLine
  • MarketsandMarkets
  • Orbys Black Book
  • Ovum
  • Technavio
  • Timetric Ltd
  • Verdict
  • World Market Intelligence
  • YouGov
  • Zukunftsinstitut
  • Filter zurücksetzen
Sprache
  • Deutsch
  • Englisch
  • Deutsch oder Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • Filter zurücksetzen
laedt

Marktanalyse - Buyer Spend Activity in the Pharmaceutical Industry - 2012-2013 : Survey Brief

ICD Research

ICD Research

6 / 2012
51 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

541,38 €*
( 700,00 $)
PDF-Datei per E-Mail, Single User License , versandkostenfrei
1.082,75 €*
( 1.400,00 $)
PDF-Datei per E-Mail, Site License Price , versandkostenfrei
1.624,13 €*
( 2.100,00 $)
PDF-Datei per E-Mail, Enterprise License , versandkostenfrei


Marktanalyse - Buyer Spend Activity in the Pharmaceutical Industry - 2012-2013 : Survey Brief

Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Provides data on the current size of procurement budgets of buyer companies in the pharmaceutical industry.
• Provides insight into the buying behaviors of the global pharmaceutical industry and market competition for supplier companies.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how spending activities are set to change in the pharmaceutical industry in 2012-13. This report gives you access to the category-level spending behavior of leading purchase decision makers. The report also provides access to information categorized by region, company type and size.

Scope
• The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
• The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.
• The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
• This report covers data and analysis on buyer expenditure.


Reasons To Buy
• This report provides historical procurement expenditure by buyer type and region.
• This report provides analysis on the changing spending behavior of buyers by product and category.








Companies Mentioned:

NA
Inhaltsverzeichnis - Marktanalyse - Buyer Spend Activity in the Pharmaceutical Industry - 2012-2013 : Survey Brief



1 Introduction

1.1 What is This Report About?

1.2 Definitions

1.3 Methodology

1.4 Profile of Survey Respondents: Global Pharmaceutical Industry

1.4.1 Profile of buyer respondents: global pharmaceutical industry

1.4.2 Profile of supplier respondents: global pharmaceutical industry

2 Global Pharmaceutical Industry Buyer Spend Activity

2.1 Global Pharmaceutical Industry: Annual Procurement Budgets

2.1.1 Global pharmaceutical industry: annual procurement budgets by company type

2.1.2 Global pharmaceutical industry: annual procurement budgets by region

2.1.3 Global pharmaceutical industry: annual procurement budgets by company turnover

2.2 Global Pharmaceutical Industry: Planned Change in Procurement Spend

2.2.1 Global pharmaceutical industry: planned change in procurement spend by buyer type

2.2.2 Global pharmaceutical industry: planned change in procurement spend by region

2.2.3 Global pharmaceutical industry: planned change in procurement spend by company turnover

2.2.4 Global pharmaceutical industry: planned change in expenditure vs. revenue growth optimism

2.2.5 Global pharmaceutical industry: planned change in expenditure vs. cost containment

2.2.6 Global pharmaceutical industry: planned change in procurement spend - cross industry comparisons

2.3 Planned change in procurement spend by product and service category

2.3.1 Planned change in procurement spend by product and service category - region

2.3.2 Planned change in procurement spend by product and service category - company turnover

2.4 Global Pharmaceutical Industry: Variations in Regional Supplier Prices

2.4.1 Global pharmaceutical industry: variations in regional supplier prices by company type

2.4.2 Global pharmaceutical industry: variations in supplier prices by region

2.4.3 Global pharmaceutical industry: variations in regional supplier prices by company turnover

3 Appendix

3.1 Global Pharmaceutical Industry Survey Results - Closed Questions

3.2 Methodology

3.3 Contact us

3.4 About ICD Research

3.5 Disclaimer









Tabellenverzeichnis - Marktanalyse - Buyer Spend Activity in the Pharmaceutical Industry - 2012-2013 : Survey Brief



Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2012

Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012

Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012

Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012

Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012

Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012

Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012

Table 8: Annual Procurement Budgets: Global Pharmaceutical Industry Buyers in US$ (%), 2010-2012

Table 9: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Company (%), 2012

Table 10: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Region (%), 2012

Table 11: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Turnover (%), 2012

Table 12: Change in Total Procurement Expenditure of Global Pharmaceutical Industry Buyers (%), 2010-2012

Table 13: Global Pharmaceutical Industry: Change in Total Procurement Expenditure by Company Type (%), 2012

Table 14: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Region (%), 2012

Table 15: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Company Turnover (%), 2012

Table 16: Global Pharmaceutical Industry: Change in Expenditure vs. Revenue Growth (%), 2012

Table 17: Global Pharmaceutical Industry: Change in Expenditure vs. Cost Containment (%), 2012

Table 18: Planned Change in Procurement Spend: Cross Industry Comparison (%), 2012

Table 19: Global Pharmaceutical Industry Manufacturers: Change in Expenditure by Products and Services (%), 2012

Table 20: Global Pharmaceutical Industry CRO and CMO: Change in Expenditure by Products and Services (%), 2012

Table 21: Global Pharmaceutical Industry: Variations in Regional Supplier Prices (%), 2012

Table 22: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Company (%), 2012

Table 23: Global Pharmaceutical Industry: Variations in Supplier Prices by Region (%), 2012

Table 24: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Turnover (%), 2012

Table 25: Survey Results - Closed Questions









Übersichtenverzeichnis - Marktanalyse - Buyer Spend Activity in the Pharmaceutical Industry - 2012-2013 : Survey Brief



Figure 1: Annual Procurement Budgets: Global Pharmaceutical Industry Buyers in US$ (%), 2010-2012

Figure 2: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Company (%), 2012

Figure 3: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Region (%), 2012

Figure 4: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Turnover (%), 2012

Figure 5: Change in Total Procurement Expenditure of Global Pharmaceutical Industry Buyers (%), 2010-2012

Figure 6: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Company Type (%), 2012

Figure 7: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Region (%), 2012

Figure 8: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Company Turnover (%), 2012

Figure 9: Global Pharmaceutical Industry Manufacturers: Change in Expenditure by Products and Services (%), 2012

Figure 10: Global Pharmaceutical Industry CRO and CMO: Change in Expenditure by Products and Services (%), 2012

Figure 11: Global Pharmaceutical Industry: Increase in Expenditure on Products and Services by Region (%), 2012

Figure 12: Global Pharmaceutical Industry: Increase in Expenditure on Products and Services by Turnover (%), 2012

Figure 13: Global Pharmaceutical Industry: Variations in Regional Supplier Prices (%), 2012

Figure 14: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Company (%), 2012

Figure 15: Global Pharmaceutical Industry: Variations in Supplier Prices by Region (%), 2012

Figure 16: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Turnover (%), 2012

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: